These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18818403)

  • 21. Cooperation between p53 and p130(Rb2) in induction of cellular senescence.
    Kapić A; Helmbold H; Reimer R; Klotzsche O; Deppert W; Bohn W
    Cell Death Differ; 2006 Feb; 13(2):324-34. PubMed ID: 16123778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P300 plays a role in p16(INK4a) expression and cell cycle arrest.
    Wang X; Pan L; Feng Y; Wang Y; Han Q; Han L; Han S; Guo J; Huang B; Lu J
    Oncogene; 2008 Mar; 27(13):1894-904. PubMed ID: 17906698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
    Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
    Kim YJ; Jung JK; Lee SY; Jang KL
    Cancer Lett; 2010 Feb; 288(2):226-35. PubMed ID: 19656618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
    Grau R; Punzón C; Fresno M; Iñiguez MA
    Biochem J; 2006 Apr; 395(1):81-8. PubMed ID: 16343055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway.
    Deleye Y; Cotte AK; Hannou SA; Hennuyer N; Bernard L; Derudas B; Caron S; Legry V; Vallez E; Dorchies E; Martin N; Lancel S; Annicotte JS; Bantubungi K; Pourtier A; Raverdy V; Pattou F; Lefebvre P; Abbadie C; Staels B; Haas JT; Paumelle R
    J Biol Chem; 2020 Dec; 295(50):17310-17322. PubMed ID: 33037071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of p16 in the E2F-dependent thymidine kinase regulation.
    Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E
    Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.
    Su S; Minges JT; Grossman G; Blackwelder AJ; Mohler JL; Wilson EM
    J Biol Chem; 2013 Aug; 288(34):24809-24. PubMed ID: 23853093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway.
    Jung JK; Arora P; Pagano JS; Jang KL
    Cancer Res; 2007 Jun; 67(12):5771-8. PubMed ID: 17575144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density.
    Wang Z; Hu H; Li G; Lee HJ; Jiang C; Kim SH; Lü J
    Int J Cancer; 2008 Jan; 122(1):15-24. PubMed ID: 17847021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the G1/S transition phase in mesangial cells by E2F1.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Oct; 56(4):1238-41. PubMed ID: 10504464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription.
    Wang CH; Chang HC; Hung WC
    J Cell Physiol; 2006 Jul; 208(1):246-52. PubMed ID: 16575904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27kip1- Dependent Mechanism.
    Yu D; Makkar G; Dong T; Strickland DK; Sarkar R; Monahan TS
    PLoS One; 2015; 10(11):e0141397. PubMed ID: 26528715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2.
    Rodier G; Makris C; Coulombe P; Scime A; Nakayama K; Nakayama KI; Meloche S
    J Cell Biol; 2005 Jan; 168(1):55-66. PubMed ID: 15631990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle.
    Tammali R; Saxena A; Srivastava SK; Ramana KV
    Endocrinology; 2010 May; 151(5):2140-50. PubMed ID: 20308528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
    Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
    Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F.
    Kim MJ; Park KG; Lee KM; Kim HS; Kim SY; Kim CS; Lee SL; Chang YC; Park JY; Lee KU; Lee IK
    Hypertension; 2005 Apr; 45(4):552-6. PubMed ID: 15723965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.